{
  "kind": "treatment",
  "slug": "diazepam-valium",
  "type": "benzodiazepine",
  "name": "Diazepam (Valium)",
  "summary": "A long-acting benzodiazepine used for anxiety disorders, muscle spasms, seizures, and alcohol withdrawal.",
  "description": "Diazepam is a long-acting benzodiazepine with anxiolytic, muscle relaxant, anticonvulsant, and sedative properties. It enhances the effect of the inhibitory neurotransmitter GABA at the GABA-A receptor. Diazepam is indicated for anxiety disorders, acute alcohol withdrawal, muscle spasticity, seizure disorders, and as premedication for procedures.",
  "category": "medications/benzodiazepines",
  "tags": [
    "benzodiazepine",
    "anxiolytic",
    "muscle-relaxant",
    "anticonvulsant",
    "sedative"
  ],
  "metadata": {
    "drug_classes": [
      "Benzodiazepine",
      "Anxiolytic",
      "Muscle Relaxant",
      "Anticonvulsant"
    ],
    "therapeutic_categories": [
      "Anxiety",
      "Seizure Disorders",
      "Muscle Spasms",
      "Alcohol Withdrawal"
    ],
    "mechanism_categories": [
      "GABA"
    ],
    "administration_routes": [
      "Oral",
      "Injection",
      "Other"
    ],
    "prescription_status": "Prescription Required",
    "controlled_substance": true,
    "generic_available": true,
    "brand_names": [
      "Valium"
    ],
    "dea_schedule": "IV",
    "fda_pregnancy_category": "D",
    "age_groups": [
      "Adult",
      "Pediatric",
      "Geriatric"
    ],
    "treatment_duration": [
      "Short-term"
    ],
    "specialty_areas": [
      "Psychiatry",
      "Neurology",
      "Emergency Medicine"
    ],
    "fda_approval_year": 1963
  },
  "clinical_metadata": {
    "primary_indications": [
      "Anxiety",
      "Substance Use",
      "Other"
    ],
    "off_label_uses": [
      "Insomnia",
      "Procedural sedation"
    ],
    "contraindications": [
      "Severe respiratory insufficiency",
      "Sleep apnea syndrome",
      "Severe hepatic impairment",
      "Myasthenia gravis"
    ],
    "monitoring_required": [
      "Sedation level",
      "Respiratory status",
      "Signs of dependence or misuse"
    ],
    "efficacy_rating": {
      "anxiety": 4,
      "seizure-control": 4,
      "muscle-relaxation": 4
    }
  },
  "search_metadata": {
    "searchable_terms": [
      "diazepam",
      "valium",
      "benzodiazepine",
      "anxiety medication",
      "muscle relaxant",
      "anticonvulsant"
    ],
    "synonyms": [
      "diazepam hydrochloride"
    ],
    "common_misspellings": [
      "diazapan",
      "valyum"
    ]
  },
  "sections": [
    {
      "type": "indications",
      "items": [
        "Anxiety disorders",
        "Acute alcohol withdrawal",
        "Skeletal muscle spasticity",
        "Adjunct in seizure disorders",
        "Status epilepticus (IV)",
        "Procedural sedation and amnesia"
      ]
    },
    {
      "type": "mechanism",
      "text": "Binds to the benzodiazepine site on the GABA-A receptor, enhancing GABA's inhibitory effect by increasing chloride channel opening frequency, leading to CNS depression."
    },
    {
      "type": "dosing",
      "adult": {
        "anxiety": "2–10 mg orally, 2–4 times daily",
        "alcohol-withdrawal": "10 mg orally every 6–8 hours initially, tapering to 5 mg as needed",
        "muscle-spasm": "2–10 mg orally, 3–4 times daily",
        "status-epilepticus": "5–10 mg IV every 10–15 minutes as needed (max 30 mg in 8 hours)"
      },
      "geriatric": "Start at lower doses (e.g., 2 mg 1–2 times daily)",
      "hepatic_impairment": "Avoid in severe impairment; lower doses in mild/moderate",
      "renal_impairment": "Use with caution; no formal dose adjustment"
    },
    {
      "type": "dosage_forms",
      "items": [
        "Tablets: 2 mg, 5 mg, 10 mg",
        "Oral solution",
        "Injectable solution",
        "Rectal gel"
      ]
    },
    {
      "type": "onset_duration",
      "text": "Onset: 15–60 minutes orally, 1–5 minutes IV; Duration: 12–24 hours"
    },
    {
      "type": "adverse_effects",
      "common": [
        "drowsiness",
        "fatigue",
        "muscle weakness",
        "ataxia"
      ],
      "less_common": [
        "confusion",
        "blurred vision",
        "slurred speech"
      ],
      "serious": [
        "respiratory depression",
        "dependence",
        "withdrawal seizures"
      ]
    },
    {
      "type": "warnings",
      "black_box": "Concomitant use with opioids may result in profound sedation, respiratory depression, coma, and death.",
      "other": [
        "Risk of dependence and withdrawal; limit duration of use",
        "Avoid abrupt discontinuation"
      ]
    },
    {
      "type": "interactions",
      "items": [
        {
          "with": "Opioids",
          "risk": "Respiratory depression",
          "action": "Avoid or monitor closely"
        },
        {
          "with": "Alcohol",
          "risk": "Additive CNS depression",
          "action": "Avoid"
        },
        {
          "with": "Other CNS depressants",
          "risk": "Excessive sedation",
          "action": "Use lowest effective doses"
        }
      ]
    },
    {
      "type": "monitoring",
      "items": [
        "Sedation and respiratory status",
        "Signs of misuse or dependence",
        "Symptom control for anxiety or withdrawal"
      ]
    },
    {
      "type": "special_populations",
      "pregnancy": "Category D; risk of fetal harm and neonatal withdrawal",
      "lactation": "Excreted in breast milk; avoid or monitor infant closely",
      "pediatrics": "Use only when clearly indicated",
      "geriatrics": "Increased sensitivity; use lower doses"
    },
    {
      "type": "tapering",
      "text": "Gradual dose reduction recommended to prevent withdrawal symptoms such as anxiety, insomnia, and seizures."
    },
    {
      "type": "clinical_notes",
      "items": [
        "Long half-life may lead to accumulation, especially in elderly",
        "Not recommended for long-term management of anxiety due to dependence risk"
      ]
    },
    {
      "type": "references",
      "items": [
        {
          "label": "Valium Prescribing Information",
          "url": "https://www.accessdata.fda.gov/"
        },
        {
          "label": "Benzodiazepine Guidelines",
          "url": "https://www.nice.org.uk/"
        }
      ]
    }
  ],
  "seo": {
    "title": "Diazepam (Valium): Dosing, Indications, Side Effects",
    "description": "Comprehensive overview of diazepam (Valium) including dosing, uses, warnings, and adverse effects."
  }
}
